Free Trial

Trupanion (TRUP) Competitors

Trupanion logo
$51.82 -1.14 (-2.15%)
(As of 11/20/2024 ET)

TRUP vs. BNRE, VOYA, JXN, ESNT, FG, BWIN, ACT, GSHD, OSCR, and HGTY

Should you be buying Trupanion stock or one of its competitors? The main competitors of Trupanion include Brookfield Reinsurance (BNRE), Voya Financial (VOYA), Jackson Financial (JXN), Essent Group (ESNT), F&G Annuities & Life (FG), The Baldwin Insurance Group (BWIN), Enact (ACT), Goosehead Insurance (GSHD), Oscar Health (OSCR), and Hagerty (HGTY). These companies are all part of the "insurance" industry.

Trupanion vs.

Brookfield Reinsurance (NYSE:BNRE) and Trupanion (NASDAQ:TRUP) are both mid-cap finance companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, community ranking, risk, media sentiment, profitability, valuation and institutional ownership.

Brookfield Reinsurance has a net margin of 0.10% compared to Trupanion's net margin of -1.08%. Brookfield Reinsurance's return on equity of 0.14% beat Trupanion's return on equity.

Company Net Margins Return on Equity Return on Assets
Brookfield Reinsurance0.10% 0.14% 0.01%
Trupanion -1.08%-4.36%-1.69%

Trupanion received 527 more outperform votes than Brookfield Reinsurance when rated by MarketBeat users. Likewise, 65.79% of users gave Trupanion an outperform vote while only 0.00% of users gave Brookfield Reinsurance an outperform vote.

CompanyUnderperformOutperform
Brookfield ReinsuranceOutperform Votes
No Votes
Underperform Votes
2
100.00%
TrupanionOutperform Votes
527
65.79%
Underperform Votes
274
34.21%

Brookfield Reinsurance has a beta of 1.53, meaning that its stock price is 53% more volatile than the S&P 500. Comparatively, Trupanion has a beta of 1.69, meaning that its stock price is 69% more volatile than the S&P 500.

In the previous week, Trupanion had 4 more articles in the media than Brookfield Reinsurance. MarketBeat recorded 4 mentions for Trupanion and 0 mentions for Brookfield Reinsurance. Trupanion's average media sentiment score of 1.05 beat Brookfield Reinsurance's score of 0.00 indicating that Trupanion is being referred to more favorably in the news media.

Company Overall Sentiment
Brookfield Reinsurance Neutral
Trupanion Positive

Trupanion has a consensus price target of $44.67, indicating a potential downside of 13.80%. Given Trupanion's stronger consensus rating and higher probable upside, analysts plainly believe Trupanion is more favorable than Brookfield Reinsurance.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Brookfield Reinsurance
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Trupanion
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.71

Brookfield Reinsurance has higher revenue and earnings than Trupanion. Trupanion is trading at a lower price-to-earnings ratio than Brookfield Reinsurance, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Brookfield Reinsurance$9.35B0.88$796M$0.29194.62
Trupanion$1.11B1.98-$44.69M-$0.32-161.94

7.2% of Brookfield Reinsurance shares are held by institutional investors. 1.0% of Brookfield Reinsurance shares are held by company insiders. Comparatively, 5.5% of Trupanion shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Trupanion beats Brookfield Reinsurance on 11 of the 19 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TRUP vs. The Competition

MetricTrupanionHospital & medical service plans IndustryFinance SectorNASDAQ Exchange
Market Cap$2.19B$66.79B$10.51B$8.90B
Dividend YieldN/A1.53%10.13%4.07%
P/E Ratio-161.9415.0446.1813.46
Price / Sales1.980.693,478.9287.66
Price / CashN/A9.1830.6036.27
Price / Book6.855.174.066.30
Net Income-$44.69M$3.04B$1.02B$225.93M
7 Day Performance-0.80%0.89%-0.05%-1.32%
1 Month Performance-3.88%-0.93%7.13%0.60%
1 Year Performance93.50%37.90%24.11%26.23%

Trupanion Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TRUP
Trupanion
2.2124 of 5 stars
$51.82
-2.2%
$44.67
-13.8%
+95.0%$2.19B$1.11B-161.941,142Positive News
BNRE
Brookfield Reinsurance
N/A$56.44
-0.7%
N/A+63.2%$8.21B$9.35B194.624,000
VOYA
Voya Financial
4.9315 of 5 stars
$80.36
+0.5%
$86.00
+7.0%
+12.8%$7.73B$7.71B12.729,000Positive News
JXN
Jackson Financial
1.7721 of 5 stars
$99.57
+1.0%
$84.00
-15.6%
+114.3%$7.35B$3.16B-7.803,840
ESNT
Essent Group
4.2673 of 5 stars
$55.71
-0.1%
$65.00
+16.7%
+14.3%$5.92B$1.11B8.08350Positive News
FG
F&G Annuities & Life
1.6936 of 5 stars
$45.41
-0.5%
$46.33
+2.0%
+10.0%$5.73B$4.50B0.001,165Positive News
BWIN
The Baldwin Insurance Group
2.0214 of 5 stars
$45.71
+0.5%
$47.17
+3.2%
N/A$5.37B$1.22B-71.053,927
ACT
Enact
N/A$34.10
+0.5%
$35.00
+2.6%
+21.9%$5.24B$1.15B7.87500Dividend Announcement
Ex-Dividend
GSHD
Goosehead Insurance
3.3716 of 5 stars
$120.70
+0.2%
$97.90
-18.9%
+64.6%$4.48B$261.28M167.271,415Analyst Forecast
OSCR
Oscar Health
3.3192 of 5 stars
$17.26
+1.5%
$22.93
+32.8%
+105.2%$4.27B$5.86B0.002,400
HGTY
Hagerty
1.6332 of 5 stars
$11.06
-0.8%
$11.00
-0.5%
+26.8%$3.77B$1.00B100.551,732

Related Companies and Tools


This page (NASDAQ:TRUP) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners